The United States vaccine market is projected to grow significantly from 2025 to 2034, driven by rising immunisation programs, advancements in vaccine technology, and the increasing prevalence of preventable diseases. With innovations in mRNA vaccines and new product launches, the market is expected to expand, supported by government initiatives and growing investments in R&D. Key players include Pfizer, Moderna, and Johnson & Johnson, focusing on expanding vaccine portfolios and addressing emerging health challenges.
https://www.expertmarketre...